News
Ark Invest made significant trades in TSLA, TXG, NTLA, DDD, and ADPT. Purchase of TXG and NTLA from ARKG and ARKK funds, and sale of TSLA, DDD, and ADPT from various funds.
In Friday’s trading session, Cathie Wood’s ARK ETFs made several notable moves, with the most significant being the purchase ...
Gov. Kemp and Georgia senator hopefuls Buddy Carter and John King have embraced the budget bill, leaving Sen. Ossoff, other Democrats trying to stop, or at least soften, it ...
The average of price targets set by Wall Street analysts indicates a potential upside of 43.1% in 10x Genomics (TXG). While the effectiveness of this highly sought-after metric is questionable, the ...
Gene sequencing technology company 10x Genomics (NASDAQ: TXG) hasn't been having it easy in the past few days on the stock ...
Genomics (TXG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Travel agency manager Hafizul Hawari applied for a plea bargain at the Sessions Court in Sepang, Selangor, on Monday (May 19) ...
TSX:TXG Earnings and Revenue History May 15th 2025 A Closer Look At Torex Gold Resources' Earnings. In high finance, the key ratio used to measure how well a company converts repo ...
The average of price targets set by Wall Street analysts indicates a potential upside of 55.9% in 10x Genomics (TXG). While the effectiveness of this highly sought-after metric is questionable, the ...
The latest price target for 10x Genomics (NASDAQ:TXG) was reported by Morgan Stanley on May 19, 2025. The analyst firm set a price target for $18.00 expecting TXG to rise to within 12 months (a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results